LiquidCell Dx, a next generation cancer diagnostics company, today announced publication in Nature of critical research underpinning the development of LiquidTME, its blood-based assay for tumor ...

A simple blood test can reveal the geographic relationships among healthy cells surrounding a cancerous tumor, researchers at ...

Abnormal cell proliferation is a major hallmark of cancer. Several proteins are involved in the cell cycle, and most of these regulate the positive or negative control of cyclin-dependent kinases.

As people age, their immune function gradually declines, coinciding with increased cancer rates. However, the precise reasons behind age-related dysfunction of CD8+ T cells in cancer remain unclear.

This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells ...

T cells dynamically adapt to signals in the TME, transitioning between effector, exhausted, and regulatory states. Cellular interactions, metabolic stress, and physical barriers (e.g., ECM) shape ...

Comparative Outcomes of Survival and Relapse After High-Dose-Rate Brachytherapy Versus External-Beam Radiotherapy Boost Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer in ...

There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these resistance mechanisms are not yet fully ...

Stanford Medicine and Mayo Clinic researchers have developed the first noninvasive blood test to map the tumor microenvironment, revealing nine cellular 'neighborhoods' linked to cancer growth and ...

Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into a suppressed state. This previously unrecognized molecular interaction, ...